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Abstract: A hallmark of Parkinsons disease is the death of
neuromelanin-pigmented neurons, but the role of neuromela-
nin is unclear. The in situ characterization of neuromelanin
remains dependent on detectable pigmentation, rather than
direct quantification of neuromelanin. We show that direct,
label-free nanoscale visualization of neuromelanin and asso-
ciated metal ions in human brain tissue can be achieved using
synchrotron scanning transmission x-ray microscopy (STXM),
through a characteristic feature in the neuromelanin x-ray
absorption spectrum at 287.4 eV that is also present in iron-free
and iron-laden synthetic neuromelanin. This is confirmed in
consecutive brain sections by correlating STXM neuromelanin
imaging with silver nitrate-stained neuromelanin. Analysis
suggests that the 1s–s* (CS) transition in benzothiazine
groups accounts for this feature. This method illustrates the
wider potential of STXM as a label-free spectromicroscopy
technique applicable to both organic and inorganic materials.
Introduction
Visualization of neuromelanin (NM), a biological poly-
mer formed by autoxidation of dopamine and cysteine within
dopamine and noradrenaline synthesizing neurons, histori-
cally relied on the presence of visible pigmentation, with or
without staining enhancement. In 1988, Hirsch and co-work-
ers highlighted how this, by definition, restricts NM visual-
ization to forms of NM with detectable pigment, thereby
excluding clusters that are too faint to view using light
microscopy.[1] This need for a neuromelanin-specific marker
has not been met in over three decades, with studies
continuing to depend on the natural contrast of the NM
pigment viewed under an optical or electron microscope.[2]
This constrains objective investigation of NM in human
health and disease, and in other species in which pigmentation
is less apparent, carrying an implicit suggestion that the
quantity of NM is simply proportional to the detectable
pigmentation.
In the human brain, dopaminergic neurons within the
substantia nigra normally show pigmentation with advancing
age as granules of NM. These neurons are particularly
vulnerable during the progression of Parkinsons disease
(PD)[1] and related disorders. In PD, loss of pigmentation is
particularly evident in the substantia nigra pars compacta and
is directly associated with progressive neuronal loss. PD is the
second most common neurodegenerative disease globally,
and remains incurable, whilst the underlying causes are still
unknown.[3] By the time a patients symptoms become
apparent, 80% of dopaminergic neurons may have already
died. The dopamine depletion resulting from death of the
substantia nigra neurons gives rise to the typical clinical
symptoms observed for PD patients, including tremor,
rigidity, and bradykinesia. Whilst no consensus has been
reached regarding any biological function of NM, and a direct
relationship between neuron vulnerability and the presence
of NM remains unclear, the strong affinity of NM for metal
ions is a factor receiving considerable attention.[4]
NM has been proposed as the main chelator of neuronal
iron in the substantia nigra, and 50-fold increased concen-
trations of iron compared to surrounding tissue have been
observed.[5] NM has been shown to sequester Fe2+ ions and
bind them as Fe3+, creating iron oxide clusters, which
comprise approximately 10–20% of total iron in the sub-
stantia nigra.[6] The remaining iron is mostly stored by ferritin
in the glia.[6] Since PD is associated with a marked increase in
nigral iron concentration,[7] it is imperative to discern the
individual roles played by these two iron storage compounds
if normal physiological iron concentration is exceeded.
Within the brain, NM is contained within organelles 0.5–
3 mm in size, along with proteins, lipid bodies, and bound
metal ions. NM clusters in the substantia nigra range from
200–600 nm in size, and are divided into spherical granules of
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circa 30 nm diameter.[8] Diffraction studies indicate that the
NM polymer itself consists of a central protein core with
a similar structural motif to b-pleated sheets of amyloid
aggregates (b strands that run perpendicular to the fiber axis,
forming a cross-b sheet), surrounded by an unstructured
melanic polymer.[6,7c,9] The melanic portion can itself be
divided into two structural components. Pheomelanin is
formed first by oxidative co-polymerization of cysteine and
dopamine and characterized by benzothiazine groups. Once
cysteine levels have been depleted, slower oxidative homo-
polymerization of dopamine results in the formation of
eumelanin, which is characterized by dihydroxyindole groups
and forms at the surface of the pheomelanin.[10] Partial
structures for eumelanin and pheomelanin are displayed in
Figure 1, alongside structures of the precursors dopamine and
l-cysteine.
The ability of NM to sequester iron and other metals in
a non-reactive form is thought to act as an intrinsic defense
against labile metal ion accumulation. Binding of metal ions
to the insoluble NM restricts their participation in extracel-
lular redox activity, thereby shielding surrounding cells from
oxidative stress and associated toxicity.[7d,9] This putative
protective role of NM is consistent with its accumulation in
the brain during ageing, its affinity for toxic compounds, and
its ability to remove cytosolic catechols.[4b] Conversely, iron
released by NM into the extra-cellular milieu may stimulate
oxidative stress mechanisms, contributing to the selective
neurodegeneration of pigmented neurons. If NM is released
from the cell upon cell death, NM–iron complexes may
activate microglia to release cytokines and neurotoxins,
inducing a vicious cycle of chronic inflammation and neuronal
loss in the PD substantia nigra.[7d,9, 11] Thus it has been
hypothesized that NM may play a protective or destructive
role depending on cellular context.[9]
Synthetic models of NM have been explored by several
groups.[12] Such analogues are essential, since isolating NM
from substantia nigra tissue is highly challenging and yields
only small quantities.[12b] Wider investigation into the dual
protective/damaging role of NM is reliant on in vitro and
ex vivo studies being carried out with sufficient sensitivity to
detect chemical or structural changes relating to NM–metal
binding. This of course depends a priori on the ability to
identify accurately NM in brain tissue. Histochemical tech-
niques are traditionally used for melanin visualization,
including the DOPA oxidase, ferrous iron, and Masson-
Fontana methods.[13] The propensity of NM to be labelled
using silver stains, similar to other melanins, is indeed partly
responsible for its original melanin classification.[14] Numer-
ous studies have identified the presence of NM using the
Masson-Fontana silver stain,[2b,15] which causes melanin to
appear black as it reduces ammoniacal silver nitrate to
metallic silver.[16] However, for trace metal analysis, staining is
an unsuitable mapping technique, as it alters the native
chemistry and prohibits the accurate speciation of associated
metal ions. Contrast agents routinely used to prepare samples
for microscopic imaging also eliminate the potential for in situ
chemical analysis.
Good sample preservation is essential for optimal chem-
ical imaging analysis of delicate biological materials. A key
advantage of x-ray imaging is that significantly reduced beam
damage is expected from x-ray beam exposure compared to
electron beam exposure at equivalent spatial resolution.[17]
Additionally, whilst conventional electron microscopy may be
hampered by over-sensitivity to electron-dense material, the
greater penetrating power of x-ray microscopy is beneficial
for characterizing the fine structure of electron-dense materi-
als such as melanin granules.[18]
Scanning transmission x-ray microscopy (STXM) is a syn-
chrotron-based spectromicroscopy technique that combines
excellent chemical sensitivity with high-resolution microsco-
py. Usually employed in the soft x-ray range (circa 0.1–1 keV)
for biological samples, this approach permits access to both
organic and inorganic (metal) absorption edges without the
necessity for artificial staining (typically required for light or
electron microscopy).[17,19] Soft x-ray microscopy is capable of
spanning the water window (280–540 eV range), in which
there is an order of magnitude difference between absorption
coefficients for water and protein.
In STXM, monochromatic x-rays are focused into a nano-
meter-sized spot (pixel) on the sample using a zone plate. A
microscopic image is generated by raster scanning the sample
in the focal plane of the zone plate whilst measuring
transmitted x-ray intensity for each pixel. When the incident
x-ray energy is stepped over a range (typically over a targeted
absorption edge), spectra can be obtained, providing infor-
mation about the sample composition. STXM is a technique
that has benefited from vast improvements in beam focusing
and detector sensitivity, such that it is now capable of
characterizing chemical composition over 50 nm-sized areas
at sub-part-per-million sensitivity.[17] Thin sections used for
STXM (100–200 nm) permit spectra to be collected at the
Figure 1. Structures of the neuromelanin precursors, dopamine and
l-cysteine, alongside partial structures of eumelanin (NM surface)
and pheomelanin (NM core). Dihydroxyindole=green and benzothia-
zine= red.
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carbon K-edge, allowing metal speciation to be correlated
with protein distribution. This has been previously demon-
strated to good effect in detailed characterizations of
amyloid-b/iron aggregates formed in vitro,[20] ex vivo human
brain tissue,[19] and amyloid plaque cores extracted from
Alzheimers disease brain tissue.[21]
In addition, the ability to generate image contrast
artificially by exploiting specific spectral features, uniquely
allows the technique to be used to map selectively structures
for which histological stains do not exist. This was exploited
recently by using spectral features measured at the carbon K-
edge, to map variations observed when extracellular peptides
were bound to iron in cortical tissue from a transgenic mouse
model of Alzheimers disease.[22]
Herein, we establish the potential of STXM for label-free
mapping of NM in human brain substantia nigra pars
compacta tissue from both PD and non-PD cases, and
evaluate NM–metal binding. Method development is in-
formed with x-ray absorption spectra from reference materi-
als to assess signal specificity and likely origin of spectral
features associated with NM.
To date, advances in understanding PD etiology have been
hampered by a lack of tools for investigating interactions
between organic and inorganic (metal ion) phases in the PD
brain, since most methods demand a mutually exclusive
choice be made between performing an analysis of the organic
or inorganic properties of a particular tissue sample. In
recognizing the importance of this system, Biesemeier and co-
workers noted in 2016 the surprising lack of high-resolution
chemical analysis and imaging studies to investigate the
interaction between NM and iron.[8] Herein, we show that soft
x-ray spectromicroscopy can address this technical challenge,
and provide new insights into the metallomics of PD and
related disorders.
Results
Speciation maps and x-ray absorption spectra were
collected from resin-embedded substantia nigra tissues at
the carbon K-edge, focusing on NM-rich regions within
dopaminergic neurons and regions of tissue adjacent to the
neurons (neuropil). Full procedures for generating speciation
maps and absorption spectra are shown in Supporting
Information Figures S1 and S2, respectively. A particular
advantage of STXM, as illustrated in Figure S1, is the capacity
to display signal(s) from analytes of interest (e.g., neuro-
melanin, Figure S1c, and protein, Figure S1e) without inter-
ference from artefacts such as score marks from tissue
sectioning. Carbon K-edge absorption spectra were also
collected from resin-embedded in vitro standards, alpha-
synuclein, ferritin, synthetic NM (with and without iron-
loading), and benzothiazine, in order to evaluate contribu-
tions to the tissue spectra.
Optical images were initially used to locate dopaminergic
neurons within substantia nigra tissue prior to STXM analysis,
see Figure 2a,b. The NM pigment was just visible without
staining, with enhanced contrast appearing after staining.
For case PD1 (Supporting Information Table S1), the
same cell shown in Figure 2 was successfully identified by
optical microscopy in a consecutive, unstained section and
mounted for STXM analysis. Scanning at 287 eV, a NM-rich
region within the cell was selected, guided by the optical
micrograph of the paired stained section shown in Figure 2b.
A neuropil region was selected by first creating a protein
speciation map; an off-peak image (290.5 eV) was subtracted
from a peak image taken at 288.6 eV, corresponding to an
amide 1s!p* transition in tissue-derived protein. The
resultant map displayed the tissue ultrastructure within the
section, as shown in Figure 2c.
A series of images (“stack”) across the carbon K-edge
(280–320 eV) was acquired within both NM-rich and neuropil
regions in PD substantia nigra (Figure 3) in order to compare
the absorption spectra. The spectrum acquired from the
neuropil region was defined by three clear peaks at 285.5,
288.6, and 290 eV. The peaks at 285.5 and 288.6 eV can be
attributed to the 1s!p* transitions for aromatic and amide
groups, respectively.[23] The peak at 289.8 eV can be attributed
to 1s!s*(C-N) transitions in various amino acids, including
arginine and asparagine.[24] The spectrum acquired from the
intracellular NM region exhibited suppression of the principal
amide peak (288.6 eV) compared to protein, and the appear-
Figure 2. Dopaminergic neuron identified in PD (case PD1) substantia
nigra pars compacta (SNc) tissue section (200 nm thickness) using
optical microscopy, then mapped using STXM at the carbon K-edge
and Iron L-edge in a consecutive tissue section. a) Unstained cell,
b) Masson-Fontana stained cell, arrow marks the position of a fold
introduced into the resin by staining, c) protein speciation map,
d) NM speciation map using peak at 287.4 eV, e) iron map, f) compo-
site map showing protein (blue), NM (green) and iron (red). The
individual RBG color channels were manually adjusted for display
purposes.
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ance of a doublet feature, including a characteristic peak at
287.4 eV that was not observed in the tissue spectrum, but
that was also found in the synthetic NM spectra. Spatial
resolution of 100 nm enabled individual NM granules to be
easily discerned from surrounding tissue at 287.4 eV (Fig-
ure S2).
An additional speciation map was created by subtracting
an off-peak image (290.5 eV) from an image acquired at
287.4 eV, where the characteristic NM absorption feature was
observed. This is shown in Figure 2d. By acquiring large-area
STXM maps of the whole cell body at 200 nm spatial
resolution, a detailed depiction of granular morphology and
distribution of NM could be resolved.
Correlation analysis of an optical image acquired from
a Masson-Fontana stained section (Figure 2b), and a STXM
NM speciation map in the corresponding adjacent section
(Figure 2d) confirmed a spatial correlation between the
optical and synchrotron-measured cellular distributions of
NM. The correlation coefficient was 0.71 for the cell body,
excluding the region with the folding artefact (Supporting
Information Figure S3).
The same neuron from case PD1 was further analysed at
the Fe L3-absorption edge to examine the distribution of iron
within NM granules. The cell was shown to be heavily loaded
with iron (Figure 2e), with a distribution closely matching
that of NM. Cross-correlation of the entire cell body area in
the synchrotron-acquired NM and iron maps yielded a corre-
lation coefficient of 0.76 (Figure S3), and for the spatial
region defined in Figure S3a,b the correlation coefficient for
synchrotron-acquired NM and iron maps was equivalent
(0.75). Additional examples of correlative staining and NM
mapping are shown for a neurologically healthy control case
in Figures S4 and S5.
Carbon K-edge absorption spectra collected from both
iron-free and iron-loaded synthetic NM analogues are shown
alongside intracellular NM from PD1 in Figure 3. The
absorption feature at 287.4 eV was reproduced in both the
intracellular and synthetic NM spectra. Linear combination
fitting of the intracellular NM spectrum from case PD1 was
performed to ascertain how well the spectrum could be
explained in terms of contributions from tissue-derived
protein and synthetic NM (i.e., pure dopamine/cysteine
polymer). Fitting was limited to the energy range between
283.5 and 290.5 eV in order to focus on the features of
interest. A weighted fit of the intracellular NM spectrum was
consistent with 21% tissue-derived protein and 79% NM
(69% iron-loaded synthetic NM, 10% iron-free synthetic
NM).
Figure 4 shows carbon K-edge absorption spectra ac-
quired from precursors dopamine and l-cysteine alongside
the spectrum for intracellular NM, previously shown in
Figure 3.
Spectra for benzothiazine, which occurs as a functional
group within the pheomelanin structure (see Figure 1), as well
as the intracellular proteins alpha-synuclein and ferritin are
also compared. It can be seen that the overall NM spectrum is
distinct from those of its precursor materials. However,
a broad feature centered at 287.4 eV is evident in the
spectrum of l-cysteine and a much sharper absorption feature
is present in the benzothiazine spectrum at 287.4 eV, precisely
matching the energy position of the characteristic NM
absorption feature.
Having discovered and described the spectral feature that
permitted NM mapping in PD (case PD1), this spectral
feature was confirmed in a second case of PD (PD2), and
further applied to NM imaging of post-mortem tissue from
subjects with Alzheimers disease, neurodegeneration with
brain iron accumulation, and a healthy control. The NM
contrast was consistently observed in all examples as illus-
trated in Figure 5.
Figure 3. Carbon K-edge x-ray absorption spectra from intracellular
NM in PD substantia nigra (case PD1), synthetic NM, synthetic
NM+Fe and neuropil region, highlighting an absorption feature that
enables specific isolation of NM signal from surrounding tissue
without staining. Traces are vertically offset for clarity. A dotted line
marks the position of the absorption feature attributed to NM at
287.4 eV, which is not observed within the NM-free tissue region.
Results from linear combination fitting of the intracellular NM
spectrum are over-plotted with a dashed line. Intracellular NM was
consistent with 21% protein and 79% NM (69% NM+Fe, 10% NM),
with c2 value of 0.04 obtained for the fit. The difference between NM
and NM+Fe is sufficient to affect fit quality, but we note (as
evidenced in the individual traces shown), the differences between NM
and NM+Fe arise predominantly from the relative amplitude of
features rather than presence or absence of peaks in the energy
spectrum. An expanded view of the feature in the energy region 286.5–
288.5 eV is shown in the panel on the right.
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Discussion
Comparison of x-ray absorption spectra obtained from
NM-rich and neuropil regions within substantia nigra tissue
revealed differences between NM polymer and tissue-derived
protein. We show how a distinguishing feature present in the
NM spectrum at 287.4 eV, but absent in the tissue-derived
protein spectrum, can be exploited for selective label-free
mapping of NM in tissue, without the necessity for chemical
staining. Indeed, neuromelanin contrast arising from the
spectral feature centered at 287.4 eV was consistently ob-
served in substantia nigra tissue from the five independent
cases, irrespective of disease classification (Table S1). This
suggested approach was supported by comparing neurome-
lanin maps obtained with conventional silver nitrate staining
and label-free STXM analysis, in consecutive sections from
case PD1 (Figure S3). The high spatial resolution of STXM
enabled individual neuromelanin granules to be clearly
resolved, such that correlated NM distributions were evi-
denced both with and without staining.
The structural relevance of the synthetic NM analogues
(both with and without iron loading) was demonstrated by
comparing their absorption spectra with that obtained from
intracellular NM. The same characteristic shape was observed
in all three cases, with peaks present at the same energy
values. In future, for in vitro studies, STXM could be
employed to trace NM distribution in complex model systems
for example, in competitive metal binding experiments.
Linear combination fitting suggested that intracellular NM
is composed of part protein and part NM polymer, consistent
with the multiple structural components of intracellular NM
reported in the literature.[6,25]
Previously, Biesemeier and co-workers used NanoSIMS
to demonstrate that elevated sulfur levels in NM distinguish
NM from surrounding tissue.[8] In the present work, we
mapped x-ray fluorescence at 200 nm resolution in NM-rich
regions of PD substantia nigra tissue, obtaining maps at the
iron and sulfur K-edges as shown in Figure S6. Although
sulfur is unambiguously elevated in NM, consistent with the
prior observation, sulfur is ubiquitously distributed through-
out human brain tissue in amino acid residues cysteine and
methionine, as well as other thiols, disulfides, and sulfates.
Our STXM work utilizing a signature in the NM spectrum,
present in both intracellular and synthetic NM, provides an
independent marker. Advantages conferred by this include
capacity to differentiate unambiguously deposits of extracel-
lular NM from other material such as concentrated sulfate,
and the benefit of simultaneously mapping the surrounding
tissue using another absorption feature present in the carbon
K-edge spectrum, allowing both signals to be extracted from
a single measurement.
The ability to distinguish NM from surrounding tissue
without staining or prerequisite identification of intact cells is
highly useful for mapping NM over relatively large (milli-
meter-sized) areas; however, STXM also has capacity to focus
over micron-sized regions of interest at nanoscale resolution.
The scope for characterization of both organic and inorganic
tissue components using STXM over these length scales has
been previously demonstrated.[19,21] Hence, it is important to
consider also the potential for distinguishing NM from other
intracellular constituents, particularly those with affinity for
metal ions. Figure 4 indicates that x-ray absorption spectros-
copy (XAS) at the carbon K-edge may indeed be used to
differentiate NM from the iron storage protein, ferritin, and
the dominant constituent of Lewy bodies, alpha-synuclein.
Given the relative ease with which soft x-ray techniques can
switch between organic and inorganic (metal) edges, STXM
could be further applied to examine NM-bound metals
independent of ferritin-/synuclein-bound metals within the
same cell. Moreover, the nanoscale resolution of STXM
permits characterization of sub-micron-sized deposits that
Figure 4. Carbon K-edge x-ray absorption spectra from intracellular
NM, precursors dopamine and l-cysteine, intra-cellular components
ferritin and alpha-synuclein, and NM functional group benzothiazine.
A dotted line marks the position of the absorption feature distinguish-
ing NM at 287.4 eV, shown to be dominant in the benzothiazine
spectrum, but absent in the other presented carbon spectra. A dashed
line marks the position of the principal amide peak at 288.6 eV.
Spectra acquired for all samples shown (except intracellular NM and
ferritin) were subjected to 3-point smoothing for display purposes to
accommodate lower signal-to-noise above 290 eV. Traces vertically
offset for clarity.
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may be present at concentrations below the detection limits of
alternative techniques,[26] thus providing a critical opportunity
to investigate the individual role played by NM in metal ion
metabolism. This area has been largely unexplored by high-
resolution spectromicroscopy,[8] particularly in unfixed tissue
in which chemical alteration is minimized.
The precise origin of each spectral difference between
NM and NM-free tissue cannot be conclusively determined
using STXM alone; however, it is possible to speculate based
on the standards measured in this study, knowledge of the
functional groups present, and XAS data available from the
literature. The “building block principle” states that spectra
acquired from complex structures can be divided into
individual contributions from specific functional groups/
bonds.[27] Important caveats to this approach are the effects
of delocalization of electronic charge across functional groups
giving rise to newmolecular orbitals,[27] the effects of changing
bond length on overlap between orbitals,[28] and practical
restrictions on available energy resolution. Although the
number of studies that have collected XAS data frommelanin
at the carbon K-edge are very limited, comparisons to the
present study should be drawn, where possible, to limit the
influence of the aforementioned factors.
The peak at 287.4 eV, used to create NM speciation maps,
likely originates from the pheomelanin portion of NM, given
that previous XASmeasurements of eumelanin did not report
the presence of features between peaks observed at 285.5 eV
(1s!p* aromatics) and 288.6 eV (1s!p* carboxyl groups).[29]
A pronounced peak at 287.4 eV observed in the XAS
spectrum of l-cysteine has previously been ascribed to C
SH bonds, specifically the 1s!s*(CS) transition, with the
position of the peak being independent of CS bond length.[27]
The present study confirmed the appearance of a broad
feature centered at 287.4 eV in the spectrum of l-cysteine,
and whilst it is probable that this feature contributes to the
NM spectrum, Figure 4 demonstrates that neither precursor
material (dopamine or cysteine) can fully account for the
sharp feature observed at 287.4 eV in the NM spectrum.
Earlier XAS studies of synthetic and intracellular neuro-
melanin at the sulfurK-edge found that sulfur may be present
Figure 5. STXM analysis of case PD2, in which for a single neuron, speciation maps show distributions of a) NM, b) protein, c) composite map
(NM=green, protein=blue). Carbon K-edge spectra were also acquired from d) intracellular NM and e) neuropil regions to verify reproducibility
of the distinct spectral features observed in PD1 (Figure 3). (f)–(h) show application of NM mapping to post-mortem human substantia nigra
tissue as described in Table S1: f) Alzheimer’s disease (AD) case, showing NM distribution over large field of view including multiple pigmented
neurons; g) neurologically healthy case (Control), showing NM contrast associated with a single neuron; h) neurodegeneration with brain iron
accumulation (NBIA) case, showing contrast associated with neuromelanin deposits in the tissue.
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in a cysteine-like environment, or contained within a benzo-
thiazine-like ring (heterocycle containing one sulfur and one
nitrogen atom).[30] Contributions from these functional groups
would arise from the core pheomelanin component of neuro-
melanin (as shown in Figure 1) but would be absent in either
dopamine or cysteine independently. We therefore postulate
a likely influence of benzothiazine groups on the observed
NM spectrum and the characteristic feature at 287.4 eV, used
to distinguish NM polymer from surrounding tissue. On
testing this, we found that a prominent absorption peak was
indeed present in the benzothiazine spectrum at 287.4 eV,
thus supporting our hypothesis. We suggest that the 1s!s*
transition (CS) is the most plausible explanation for this
peak in the benzothiazine spectrum, since this transition has
been reported to occur around this energy in a range of
organic, sulfur-containing molecules.[24] Speciation mapping
at the carbon K-edge using a peak attributable to the 1s!s*
(CS) transition in benzothiazine could be further applied to
identify peripheral pheomelanin in a range of biological
samples, including skin and hair samples.
Conclusion
We have shown that a characteristic peak in the carbonK-
edge x-ray absorption spectrum of neuromelanin can be used
as a basis for label-free mapping of neuromelanin in human
brain tissue. Based on standards and peak assignments
reported in the literature, we show that this peak can be
assigned to a 1s!s* (CS) transition in benzothiazine
fragments found in the pheomelanin portion of neuromela-
nin. Hence, this approach could be applied to selective
visualization of pheomelanin in a range of biological samples.
This new method holds the following key advantages over
conventional staining or electron microscopy techniques:
1) Neuromelanin is visualized without reliance on detectable
pigmentation, 2) no chemicals that demonstrably displace or
alter the target species are introduced, 3) neuromelanin
distribution is isolated from those of other tissue components,
4) artefacts in the tissue (e.g., score marks) are removed upon
image subtraction, 5) effective spatial resolution is unaffected
by highly electron-dense deposits, and 6) photo-induced
damage is minimized. Straightforward switching between
characteristic edges for light and heavy elements also presents
further opportunities to correlate the distributions of neuro-
melanin with different metals implicated in Parkinsons
disease and related disorders, including iron, which was
highlighted in this study. This may help shed light on the
enigmatic role of neuromelanin.
Data Availability: The data that support the findings in
this study are available in the Warwick Research Archive
Portal (WRAP) repository, http://wrap.warwick.ac.uk/
135050/.
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Soft x-ray spectromicroscopy enables
neuromelanin visualization in human
brain tissue. This removes dependence
on optical evaluation of pigmentation or
chemical staining, opening the door to
investigating relationships between
depigmentation, metal binding, and
neurodegeneration in the most vulnera-
ble neurons in Parkinson’s disease.
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